Chemical Component Summary

Name5-BROMOTHIENYLDEOXYURIDINE
Identifiers5-(5-bromothiophen-2-yl)-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
FormulaC13 H13 Br N2 O5 S
Molecular Weight389.222
TypeNON-POLYMER
Isomeric SMILESc1cc(sc1C2=CN(C(=O)NC2=O)[C@H]3C[C@@H]([C@H](O3)CO)O)Br
InChIInChI=1S/C13H13BrN2O5S/c14-10-2-1-9(22-10)6-4-16(13(20)15-12(6)19)11-3-7(18)8(5-17)21-11/h1-2,4,7-8,11,17-18H,3,5H2,(H,15,19,20)/t7-,8+,11+/m0/s1
InChIKeyIGUZFFOBAZCVRK-VAOFZXAKSA-N

Chemical Details

Formal Charge0
Atom Count35
Chiral Atom Count3
Bond Count37
Aromatic Bond Count5

Drug Info: DrugBank

DrugBank IDDB03804 
Name5-Bromothienyldeoxyuridine
Groups experimental
Synonyms5-Bromothienyldeoxyuridine

Drug Targets

NameTarget SequencePharmacological ActionActions
Thymidine kinaseMASYPCHQHASAFDQAARSRGHSNRRTALRPRRQQEATEVRLEQKMPTLL...unknownligand
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem 446725
ChEMBL CHEMBL1231486
CCDC/CSD TUFGAC